Search research articles
Contact Us
Filters
Showing results (221-230 of 304) with videos related to
Page
of 31
Sort By:
NPJ Precision Oncology
|
February 21, 2023
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
Scientific Reports
|
March 28, 2014
Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer
Michael J McGuire, Bethany Powell Gray, Shunzi Li, et al.
Oncotarget
|
March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer
Daniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
Milena P Mak, Pan Tong, Lixia Diao, et al.
Nanotechnology
|
February 20, 2015
Morphology dependent field emission of acid-spun carbon nanotube fibers
S B Fairchild, J Boeckl, T C Back, et al.
Plos One
|
February 21, 2012
Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters
Yong He, Zhen Zhou, Wayne L Hofstetter, et al.
Cancer Research
|
May 12, 2017
CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib
Triparna Sen, Pan Tong, C Allison Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2021
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
Suresh S Ramalingam, Silvia Novello, Salih Zeki Guclu, et al.
Nature Reviews. Cancer
|
June 9, 2019
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 304) with videos related to
Sort By:
Page
of 31
NPJ Precision Oncology
|
February 21, 2023
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
Scientific Reports
|
March 28, 2014
Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer
Michael J McGuire, Bethany Powell Gray, Shunzi Li, et al.
Oncotarget
|
March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer
Daniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
Milena P Mak, Pan Tong, Lixia Diao, et al.
Nanotechnology
|
February 20, 2015
Morphology dependent field emission of acid-spun carbon nanotube fibers
S B Fairchild, J Boeckl, T C Back, et al.
Plos One
|
February 21, 2012
Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters
Yong He, Zhen Zhou, Wayne L Hofstetter, et al.
Cancer Research
|
May 12, 2017
CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib
Triparna Sen, Pan Tong, C Allison Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2021
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
Suresh S Ramalingam, Silvia Novello, Salih Zeki Guclu, et al.
Nature Reviews. Cancer
|
June 9, 2019
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Page
of 31